Effect of local delivery of Evans blue on prevention of restenosis after coronary stenting

Effect of local delivery of Evans blue on prevention of restenosis after coronary stenting - Effect of local delivery of Evans blue on prevention of restenosis after coronary stenting

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000149

Enrollment

200

Registered

2005-09-13

Start date

2000-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina pectoris, myocardial infarction

Interventions

Evans blue group: we locally administer 1cc of 2% Evans blue solution on stenting site, 3 weeks after stenting in patients with acute myocardial infarction, and immediately after stenting in patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with angina pectoris who undergo stent placement, and with acute myocardial infarction who undergo primary stent.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
To evaluate diameter stenosis and restenosis rate on follow up coronary angiogram 6 month after stenting.	—

Secondary

Measure	Time frame
To evaluate the side effects and complications of local delivery of Evans blue.	—

Countries

Japan

Contacts

Public ContactYoshiharu Fujimori

Narita Red Cross Hospital Department of Cardiology

fm@naritasekijyuji.jp0476-22-2311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026